4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase - PubMed (original) (raw)
4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase
S R von Manteuffel et al. Proc Natl Acad Sci U S A. 1996.
Abstract
It has previously been argued that the repressor of protein synthesis initiation factor 4E, 4E-BP1, is a direct in vivo target of p42mapk. However, the immunosuppressant rapamycin blocks serum-induced 4E-BP1 phosphorylation and, in parallel, p70s6k activation, with no apparent effect on p42mapk activation. Consistent with this finding, the kinetics of serum-induced 4E-BP1 phosphorylation closely follow those of p70s6k activation rather than those of p42mapk. More striking, insulin, which does not induce p42mapk activation in human 293 cells or Swiss mouse 3T3 cells, induces 4E-BP1 phosphorylation and p70s6k activation in both cell types. Anisomycin, which, like insulin, does not activate p42mapk, promotes a small parallel increase in 4E-BP1 phosphorylation and p70s6k activation. The insulin effect on 4E-BP1 phosphorylation and p70s6k activation in both cell types is blocked by SQ20006, wortmannin, and rapamycin. These three inhibitors have no effect on p42mapk activation induced by phorbol 12-tetradecanoate 13-acetate, though wortmannin partially suppresses both the p70s6k response and the 4E-BP1 response. Finally, in porcine aortic endothelial cells stably transfected with either the wild-type platelet-derived growth factor receptor or a mutant receptor bearing the double point mutation 740F/751F, p42mapk activation in response to platelet-derived growth factor is unimpaired, but increased 4E-BP1 phosphorylation is ablated, as previously reported for p70s6k. The data presented here demonstrate that 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase.
Similar articles
- Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells.
Diggle TA, Moule SK, Avison MB, Flynn A, Foulstone EJ, Proud CG, Denton RM. Diggle TA, et al. Biochem J. 1996 Jun 1;316 ( Pt 2)(Pt 2):447-53. doi: 10.1042/bj3160447. Biochem J. 1996. PMID: 8687386 Free PMC article. - The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k.
von Manteuffel SR, Dennis PB, Pullen N, Gingras AC, Sonenberg N, Thomas G. von Manteuffel SR, et al. Mol Cell Biol. 1997 Sep;17(9):5426-36. doi: 10.1128/MCB.17.9.5426. Mol Cell Biol. 1997. PMID: 9271419 Free PMC article. - Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts.
Kimball SR, Horetsky RL, Jefferson LS. Kimball SR, et al. Am J Physiol. 1998 Jan;274(1):C221-8. doi: 10.1152/ajpcell.1998.274.1.C221. Am J Physiol. 1998. PMID: 9458731 - Multiple signaling pathways involved in the metabolic effects of insulin.
Moule SK, Denton RM. Moule SK, et al. Am J Cardiol. 1997 Aug 4;80(3A):41A-49A. doi: 10.1016/s0002-9149(97)00457-8. Am J Cardiol. 1997. PMID: 9293955 Review. - p70s6k/p85s6k: mechanism of activation, effects of rapamycin and role in mitogenesis.
Thomas G. Thomas G. Biochem Soc Trans. 1993 Nov;21(4):901-4. doi: 10.1042/bst0210901. Biochem Soc Trans. 1993. PMID: 8132090 Review. No abstract available.
Cited by
- Interleukin-6 in Traumatic Brain Injury: A Janus-Faced Player in Damage and Repair.
Ciryam P, Gerzanich V, Simard JM. Ciryam P, et al. J Neurotrauma. 2023 Nov;40(21-22):2249-2269. doi: 10.1089/neu.2023.0135. Epub 2023 Aug 10. J Neurotrauma. 2023. PMID: 37166354 Review. - mTOR as a Potential Target for the Treatment of Microbial Infections, Inflammatory Bowel Diseases, and Colorectal Cancer.
Afzal O, Altamimi ASA, Mubeen B, Alzarea SI, Almalki WH, Al-Qahtani SD, Atiya EM, Al-Abbasi FA, Ali F, Ullah I, Nadeem MS, Kazmi I. Afzal O, et al. Int J Mol Sci. 2022 Oct 18;23(20):12470. doi: 10.3390/ijms232012470. Int J Mol Sci. 2022. PMID: 36293326 Free PMC article. Review. - Culprits or consequences: Understanding the metabolic dysregulation of muscle in diabetes.
O'Reilly CL, Uranga S, Fluckey JD. O'Reilly CL, et al. World J Biol Chem. 2021 Sep 27;12(5):70-86. doi: 10.4331/wjbc.v12.i5.70. World J Biol Chem. 2021. PMID: 34630911 Free PMC article. Review. - Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Blokland SLM, Hillen MR, Wichers CGK, Zimmermann M, Kruize AA, Radstake TRDJ, Broen JCA, van Roon JAG. Blokland SLM, et al. RMD Open. 2019 Jan 11;5(1):e000701. doi: 10.1136/rmdopen-2018-000701. eCollection 2019. RMD Open. 2019. PMID: 30713717 Free PMC article. No abstract available. - Beyond molecular tumor heterogeneity: protein synthesis takes control.
Ramon Y Cajal S, Castellvi J, Hümmer S, Peg V, Pelletier J, Sonenberg N. Ramon Y Cajal S, et al. Oncogene. 2018 May;37(19):2490-2501. doi: 10.1038/s41388-018-0152-0. Epub 2018 Feb 21. Oncogene. 2018. PMID: 29463861 Free PMC article. Review.
References
- Nature. 1994 Jul 7;370(6484):71-5 - PubMed
- Mol Biol Cell. 1996 Jan;7(1):25-42 - PubMed
- J Biol Chem. 1994 Sep 16;269(37):23185-91 - PubMed
- Cell. 1982 Aug;30(1):235-42 - PubMed
- Proc Natl Acad Sci U S A. 1988 Jul;85(13):4720-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous